Warning: The NCBI web site requires JavaScript to function. more...
The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells.
Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M.
Breast Cancer Res. 2005;7(3):R365-73. Epub 2005 Mar 21.
Related citations
Co-operative effect of c-Src and ezrin in deregulation of cell-cell contacts and scattering of mammary carcinoma cells.
Elliott BE, Qiao H, Louvard D, Arpin M.
J Cell Biochem. 2004 May 1;92(1):16-28.
Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP.
J Biol Chem. 2004 Dec 3;279(49):51630-46. Epub 2004 Sep 7.
Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
Li Q, Wu M, Wang H, Xu G, Zhu T, Zhang Y, Liu P, Song A, Gang C, Han Z, Zhou J, Meng L, Lu Y, Wang S, Ma D.
Cancer Lett. 2008 Mar 8;261(1):55-63. Epub 2007 Dec 26.
Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase.
Lu Z, Jiang G, Blume-Jensen P, Hunter T.
Mol Cell Biol. 2001 Jun;21(12):4016-31.
N,N'-dinitrosopiperazine-mediated ezrin protein phosphorylation via activation of Rho kinase and protein kinase C is involved in metastasis of nasopharyngeal carcinoma 6-10B cells.
Tang F, Zou F, Peng Z, Huang D, Wu Y, Chen Y, Duan C, Cao Y, Mei W, Tang X, Dong Z.
J Biol Chem. 2011 Oct 21;286(42):36956-67. Epub 2011 Aug 30.
17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin.
Zheng S, Huang J, Zhou K, Zhang C, Xiang Q, Tan Z, Wang T, Fu X.
PLoS One. 2011;6(7):e22439. Epub 2011 Jul 26.
Ezrin promotes invasion and metastasis of pancreatic cancer cells.
Meng Y, Lu Z, Yu S, Zhang Q, Ma Y, Chen J.
J Transl Med. 2010 Jun 23;8:61.
FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth.
Hauck CR, Hsia DA, Puente XS, Cheresh DA, Schlaepfer DD.
EMBO J. 2002 Dec 2;21(23):6289-302.
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.
Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ.
Nat Med. 2004 Feb;10(2):182-6. Epub 2004 Jan 4.
Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, Kung HF, Song LB, Zeng MS.
Mol Cancer. 2011 Jan 28;10(1):10.
Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
Wick W, Grimmel C, Wild-Bode C, Platten M, Arpin M, Weller M.
J Neurosci. 2001 May 15;21(10):3360-8.
Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration.
Endo K, Kondo S, Shackleford J, Horikawa T, Kitagawa N, Yoshizaki T, Furukawa M, Zen Y, Pagano JS.
Oncogene. 2009 Apr 9;28(14):1725-35. Epub 2009 Feb 23.
Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
Mitra SK, Lim ST, Chi A, Schlaepfer DD.
Oncogene. 2006 Jul 27;25(32):4429-40. Epub 2006 Mar 20.
Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells.
Brábek J, Constancio SS, Siesser PF, Shin NY, Pozzi A, Hanks SK.
Mol Cancer Res. 2005 Jun;3(6):307-15.
Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells.
Chakravarty D, Nair SS, Santhamma B, Nair BC, Wang L, Bandyopadhyay A, Agyin JK, Brann D, Sun LZ, Yeh IT, Lee FY, Tekmal RR, Kumar R, Vadlamudi RK.
Cancer Res. 2010 May 15;70(10):4092-101. Epub 2010 May 11.
Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567.
Tang F, Wang D, Duan C, Huang D, Wu Y, Chen Y, Wang W, Xie C, Meng J, Wang L, Wu B, Liu S, Tian D, Zhu F, He Z, Deng F, Cao Y.
J Biol Chem. 2009 Oct 2;284(40):27456-66. Epub 2009 Aug 3.
SHP-2 promoting migration and metastasis of MCF-7 with loss of E-cadherin, dephosphorylation of FAK and secretion of MMP-9 induced by IL-1beta in vivo and in vitro.
Wang FM, Liu HQ, Liu SR, Tang SP, Yang L, Feng GS.
Breast Cancer Res Treat. 2005 Jan;89(1):5-14.
Downregulated AP-1 activity is associated with inhibition of Protein-Kinase-C-dependent CD44 and ezrin localisation and upregulation of PKC theta in A431 cells.
Stapleton G, Malliri A, Ozanne BW.
J Cell Sci. 2002 Jul 1;115(Pt 13):2713-24.
Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R, Mahabeleshwar GH, Kundu GC.
J Biol Chem. 2004 Mar 19;279(12):11051-64. Epub 2004 Jan 2.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on